Harpoon Therapeutics, Inc.
HARPDelisted Mar 11, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001708493
Harpoon Therapeutics, Inc. was delisted on Mar 11, 2024; its insiders filed their last Form 4 on Mar 11, 2024; 41 institutions reported holding it in 13F filings for Q4 2023, worth $175.5M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Harpoon Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 93 | 1 | 84 | −8 |
| Shares | 25.8M | 228.1K | 26.0M | +427.8K (+1.7%) |
| Value | $203.9M | $1.80M | $196.3M | −$5.82M (−2.9%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held Harpoon Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Logos Global Management LP | 1,930,000 | $14.6M | 1.50% |
| Point72 Asset Management, L.P. | 650,000 | $4.91M | 0.02% |
| Marshall Wace, LLP | 235,499 | $1.78M | 0.00% |
| Kennedy Capital Management, Inc. | 129,766 | $980.0K | 0.02% |
| J. Goldman & Co LP | 67,500 | $510.0K | 0.05% |
| AQR Capital Management LLC | 29,487 | $223.0K | 0.00% |
| Sender Co & Partners, Inc. | 14,252 | $108.0K | 0.07% |
| Occudo Quantitative Strategies LP | 13,303 | $100.0K | 0.01% |
| Allspring Global Investments Holdings, LLC | 4,621 | $34.0K | 0.00% |
| Eagle Bay Advisors LLC | 1,400 | $13.0K | 0.01% |
| Aquatic Capital Management LLC | 900 | $7.00K | 0.01% |
| Advisor Group Holdings, Inc. | 641 | $5.00K | 0.00% |
| Simplex Trading, LLC | 401 | $3.00K | 0.00% |
| Washington Trust Advisors, Inc. | 90 | $1.00K | 0.00% |
| Beaird Harris Wealth Management, LLC | 149 | $1.00K | 0.00% |
Sold out (23)
Institutions that held Harpoon Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Avidity Partners Management LP | 1,190,600 | $9.41M |
| Laurion Capital Management LP | 305,954 | $2.42M |
| Affinity Asset Advisors, LLC | 250,000 | $1.98M |
| Assenagon Asset Management S.A. | 94,242 | $745.0K |
| Walleye Capital LLC | 93,106 | $736.0K |
| HRT Financial LP | 77,797 | $614.0K |
| ExodusPoint Capital Management, LP | 45,732 | $361.0K |
| Qube Research & Technologies Ltd | 44,900 | $355.0K |
| Jump Financial, LLC | 31,200 | $246.0K |
| Trexquant Investment LP | 29,435 | $233.0K |
| Walleye Trading LLC | 24,198 | $191.0K |
| Dynamic Technology Lab Private Ltd | 23,602 | $186.0K |
| Engineers Gate Manager LP | 21,600 | $171.0K |
| Pinz Capital Management, LP | 20,400 | $161.0K |
| Squarepoint Ops LLC | 14,703 | $116.0K |
| Virtus ETF Advisers LLC | 13,770 | $109.0K |
| Summit Global Investments | 10,800 | $85.0K |
| Fox Run Management, L.L.C. | 10,385 | $82.0K |
| Maven Securities LTD | 10,000 | $79.0K |
| Penserra Capital Management LLC | 745 | $5.00K |
| Captrust Financial Advisors | 516 | $4.00K |
| Point72 Hong Kong Ltd | 444 | $4.00K |
| Signaturefd, LLC | 146 | $1.00K |
Not filed for Q4 2021 yet (1)
Institutions that held Harpoon Therapeutics, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Marshall Wace North America L.P. | 228,128 | $1.80M |